688136 科兴制药
2026/09 - 九个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额6,44986,029106,670(87,135)(85,888)
投资活动产生之现金流量净额(85,297)(63,762)(104,125)(156,247)(381,446)
筹资活动产生之现金流量净额1,15973,314(10,914)16,247371,096
汇率变动对现金及现金等价物的影响(6,344)(211)1,3913,0955,432
现金及现金等价物净增加/(减少)(84,033)95,370(6,979)(224,040)(90,806)
期初现金及现金等价物余额648,322552,952559,931783,971874,777
期末现金及现金等价物余额564,289648,322552,952559,931783,971